Is chickenpox so bad, what do we know about immunity to varicella zoster virus, and what does it tell us about the future?

被引:35
|
作者
Gershon, Anne A. [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, 630 West 168th St, New York, NY 10032 USA
关键词
Varicella; Chickenpox; Zoster; Vaccination; Latency; Reactivation; GIANT-CELL ARTERITIS; KILLER T-CELLS; HERPES-ZOSTER; VACCINE-STRAIN; LONG-TERM; FATAL VARICELLA; UNITED-STATES; CHILDREN; INFECTIONS; REACTIVATION;
D O I
10.1016/S0163-4453(17)30188-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Varicella and zoster continue to cause significant morbidity and even mortality in children and adults. Complications include bacterial superinfection, central nervous system manifestations such as meningitis, encephalitis, and cerebellar ataxia, and pain syndromes especially post herpetic neuralgia. Many developed countries but not all, are now administering live attenuated varicella vaccine routinely, with a decrease in the incidence of disease, providing personal and herd immunity. There is some controversy, however, in some countries concerning whether a decrease in the circulation of wild type virus will result in loss of immunity to VZV in persons who have already had varicella. This manuscript reviews the complications of varicella and zoster in detail, the reasons for development of vaccines against these diseases, complications of vaccinations, and mechanisms by which immunity to this virus develops and is maintained. There are strong indications that the best way to control disease and spread of this virus is by vaccination against both. (C) 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S27 / S33
页数:7
相关论文
共 50 条
  • [21] Specialties & Perspectives Intersect to Tell Us What We Know about Evolution
    Glaze, Amanda L.
    [J]. AMERICAN BIOLOGY TEACHER, 2019, 81 (02): : 69 - 69
  • [22] What do accruals tell us about future cash flows?
    Barth, Mary E.
    Clinch, Greg
    Israeli, Doron
    [J]. REVIEW OF ACCOUNTING STUDIES, 2016, 21 (03) : 768 - 807
  • [23] What do accruals tell us about future cash flows?
    Mary E. Barth
    Greg Clinch
    Doron Israeli
    [J]. Review of Accounting Studies, 2016, 21 : 768 - 807
  • [24] Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
    Widgren, Katarina
    Tomba, GianPaolo Scalia
    Leung, Ka Yin
    Giesecke, Johan
    [J]. VACCINE, 2022, 40 (04) : 673 - 681
  • [25] WHAT DOES THE TERM STRUCTURE TELL US ABOUT FUTURE INFLATION
    MISHKIN, FS
    [J]. JOURNAL OF MONETARY ECONOMICS, 1990, 25 (01) : 77 - 95
  • [26] The practices of mathematicians: What do they tell us about coming to know mathematics?
    Burton L.
    [J]. Educational Studies in Mathematics, 1998, 37 (2) : 121 - 143
  • [27] Polarization: What Do We Know and What Can We Do About It?
    Casal Bertoa, Fernando
    Rama, Jose
    [J]. FRONTIERS IN POLITICAL SCIENCE, 2021, 3
  • [28] What we know and do not know about fluoride
    Newbrun, Ernest
    [J]. JOURNAL OF PUBLIC HEALTH DENTISTRY, 2010, 70 (03) : 227 - 233
  • [29] What do we know about why women bleed and what do we not know?
    James, Andra H.
    James, Paula D.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (02) : 315 - 322
  • [30] Experts amongst us: What do we know about them?
    Yates, Gregory C. R.
    Hattie, John
    [J]. JOURNAL OF EDUCATIONAL ENQUIRY, 2013, 12 (01): : 40 - 50